Parallax Volatility Advisers, L.P. Corbus Pharmaceuticals Holdings, Inc. Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$6.6 - $7.8 $79,398 - $93,834	-12,030 Reduced 98.32%	206 $1,000
Q1 2019 May 15, 2019	BUY	$5.76 - $8.95 $70,479 - $109,512	12,236 New	12,236 $85,000
Q1 2018 May 15, 2018	SELL	$5.6 - $9.25 $37,867 - $62,548	-6,762 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$6.6 - $7.78 $44,629 - $52,608	6,762	6,762 $48,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.41B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.